SlideShare une entreprise Scribd logo
1  sur  35
Kgothatso (KD) Meno
BSc (Hons)
Department of Medical Virology
Supervisor: Co-Supervisor:
Dr J Mans Prof MB Taylor
 Noroviruses are a major cause of gastroenteritis
worldwide in humans and animals
 It affects people of all ages
 Children, elderly and immunocompromised
patients are at risk of severe disease
 Norovirus is a highly contagious virus, 18 viral
particles can initiate an infection
 Transmission by means of faecal-oral route
 The symptoms shown by an individual who is
infected by NoVs include nausea, vomiting, non-
bloody watery diarrhoea and fever
 Virus shedding for 3 weeks after infection
 Prolonged in immunocompromised individuals
 200 000 deaths of children younger than five
years old has been estimated in the developing
world annually
Norovirus (NoV) - A member of Caliciviridae family
Small (30 to 35 nm), non-enveloped, icosahedral
Linear, positive sense, single-stranded RNA genome
Norovirus Genome
 ORF1/2 polymerase-capsid junction used for detection and
genotyping NoVs
 NoVs are divided into six genogroups, seventh has been
proposed (Genogroups I, II and IV infect humans)
 GII.4 is the most prevalent of all genotypes
Structural Protein
(VP1) / Major Capsid
Protein
Non-structural proteins
including RNA-dependent
RNA polymerase
 Norovirus Capsid Model of VP1 dimer
 To date no commercial NoV vaccine exists
 Virus like particles (VLP) vaccines are in clinical
trials (Atmar et al., NEJM, 2011)
 Vaccine has been shown to prevent disease but
not infection
 Studies are ongoing to evaluate combinations of
genogroups and other aspects of the vaccine
 No specific treatment or antiviral therapy for
NoV infection
 Treatment: intravenous or oral hydration
 At least 40 genotypes within the 6 genogroups
GI
GII
 A large number of gastroenteric infections and
outbreaks caused by NoVs are reported but many
suspected cases are not laboratory confirmed
 The degree of genetic variability in NoVs makes
it difficult to design sensitive and specific
molecular diagnostic assays
 This increases the need and impact of primer
design that is optimised for molecular detection
and typing
 Real-time reverse transcriptase-polymerase
chain reaction (real-time RT-PCR) is considered
the “gold standard” for detection of NoVs
 Laboratory confirmation of NoV is important in
public health remediation and prevention as well
as enhancing the understanding of NoV
prevalence in the population
 Genogroup distribution in South Africa (2009-
2015)
 GI (17.7%)
 GII (78.5%)
 GI+GII (3.8%)
 Sizable proportion caused by GI
 GI detected but not possible to genotype,
there is diversity primers are not picking up
 Since GII is studied more globally, there is
lack of information on GI because research is
skewed to GII
 The number of complete genome sequences
of GI Vs. GII
 GI is circulating a lot in SA but complete
genomes are missing
 In HIV positive children, more severe disease
is associated with GI (Prof NA Page)
 GI might be a more relevant genogroup in SA
 To optimise NoV GI genotyping primers and to
apply the newly developed genotyping assay to
study NoV GI diversity in clinical specimens and
the environment
 To genotype NoV GI detected from sewage samples (April
2015- March 2016) using standard GI primers targeting the
polymerase and capsid regions
 To construct and analyse multiple alignments of available
GI sequences from GenBank
 To design primers to optimise conventional RT-PCR
 To apply optimised methods to genotype NoV GI strains
from the Rotavirus Surveillance Sentinel Programme that
could not be typed previously (2011- 2013) and new strains
from 2015
 To amplify complete capsid gene from selected GI strains
for characterisation and phylogenetic analysis
Sample selecion
Sewage samples (Apr
2015-March 2016)
Stool specimens (<5 yrs with
diarrhoea from RSSP)
Recovery + extraction
(Victor Mabasa)
Manual nucleic acid
extraction
RNA
Primer optimisation
Genotyping
cDNA
Semi-nested RT-PCR
(partial capsid and RdRp)
Sewage
Cloning
Colony PCR
Stool Specimens
Direct sequencing
Sequencing
Phylogenetic Analysis
Rand Water Project 2015/2016
NoV GI Positive Samples – April 2015* to March 2016
4
31
9
Samples
Unscreened
Screened
Unscreened
Ct>37
n=44
0
1
2
3
4
5
6
7
8
GIpositives
Months
Representation of number of norovirus GI positive samples
detected by real-time RT-qPCR and typed by Semi-nested
conventional PCR
Real-time detection
nested PCR typing
Round 1 Round 2
1kb+
marker
PCR &
CDNA
negative
Round 1 Round 2
Round 2Round 1
M
M
M M M
1kb+
marker
M
M
Distribution of genotypes: all samples sequenced were
GI.4
25
6
4 Negative
Positive
Still to be
screened
n=35
 Collected all the complete genomes (33)
 Typed them using the norovirus genotyping
tool and aligned them using MAFFT software
in FASTA format
 Distribution of genotypes GI.1 22
GI.2 3
GI.3 2
G1.4 1
GI.6 3
GI.8 2
 GI Forward primer 1
TGG ACA GGA GAT CGC RAT CT
Tm:66°C
 GI Forward primer 2
ATG ATG ATG GCG TCT AAG GA
Tm:61°C
 GI Reverse primer
CCI ACC CAI CCA TTR TAC AT
Tm:61°C
 Problems encountered:
 Encountered problems with the Hot Start
DNA polymerase enzyme, a lot of sewage
samples were screened but there was no
amplification
 Although the enzyme worked on clinical
specimens
 The standard primer binding region not
completely conserved
 The denaturation time (30 sec) too short
 Alternative ways attempted:
 A different enzyme (Emerald) was used,
there was amplification
 High number of none specific amplification
 Emerald PCR products: Gel clean up
 Use my designed primers on the stool
specimens
 Go back and screen some of the sewage
samples with the new optimised primers and
the Hot start DNA polymerase
 Go back and screen the previously negative
sewage samples with Emerald enzyme
 Optimise the Emerald PCR
 Design genotype specific primer for capsid 3’
end
 Amplify and sequence the complete capsid
gene of selected strains
Part of a larger (ethically approved) project (Rotavirus
Sentinel Surveillance Programme), additional ethical
approval has been granted (127/2016)
Total: R71 850
 Prof NA Page together with the Rota network
 Randwater
 NRF
Any Questions?

Contenu connexe

Tendances

Current methods for plant disease diagnosis
Current methods for plant disease diagnosisCurrent methods for plant disease diagnosis
Current methods for plant disease diagnosisSHIVANI PATHAK
 
PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"StopTb Italia
 
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...African Potato Association (APA)
 
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - SOMESHWARAN R
 
Protein biomarker capabilities for Nanosphere
Protein biomarker capabilities for NanosphereProtein biomarker capabilities for Nanosphere
Protein biomarker capabilities for NanosphereWinton Gibbons
 
Role of Bioinformatics in COVID 19
Role of Bioinformatics in COVID 19Role of Bioinformatics in COVID 19
Role of Bioinformatics in COVID 19mah noor
 
Newer diagnostic methods for tuberculosis
Newer  diagnostic  methods for tuberculosis  Newer  diagnostic  methods for tuberculosis
Newer diagnostic methods for tuberculosis Shweta Anand
 
Transcriptomics: A Tool for Plant Disease Management
Transcriptomics: A Tool for Plant Disease ManagementTranscriptomics: A Tool for Plant Disease Management
Transcriptomics: A Tool for Plant Disease ManagementSHIVANI PATHAK
 
Newer investigations of tuberculosis
Newer investigations of tuberculosisNewer investigations of tuberculosis
Newer investigations of tuberculosisVishnu Ambareesh
 
I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad TECNALIA Research & Innovation
 
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...EuFMD
 
Capnocytophaga canimorsus
Capnocytophaga canimorsus Capnocytophaga canimorsus
Capnocytophaga canimorsus fateh11
 
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...dewisetiyana52
 
transforming clinical microbiology by next generation sequencing
transforming clinical microbiology by next generation sequencingtransforming clinical microbiology by next generation sequencing
transforming clinical microbiology by next generation sequencingPathKind Labs
 

Tendances (20)

Current methods for plant disease diagnosis
Current methods for plant disease diagnosisCurrent methods for plant disease diagnosis
Current methods for plant disease diagnosis
 
PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"PPT Cirillo " Diagnostic laboratory news"
PPT Cirillo " Diagnostic laboratory news"
 
NEW TECHNOLOGIES IN DIAGNOSIS OF TUBERCULOSIS
NEW TECHNOLOGIES IN   DIAGNOSIS OF TUBERCULOSIS NEW TECHNOLOGIES IN   DIAGNOSIS OF TUBERCULOSIS
NEW TECHNOLOGIES IN DIAGNOSIS OF TUBERCULOSIS
 
Listeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiologyListeria monocytogenes from population structure to genomic epidemiology
Listeria monocytogenes from population structure to genomic epidemiology
 
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru   disease mana...
Sess04 1 jari p.t. valkonen, jan f. kreuze and joseph ndunguru disease mana...
 
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS - Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
Molecular diagnosis of Mycobacterium tuberculosis TB - Second MBBS -
 
Protein biomarker capabilities for Nanosphere
Protein biomarker capabilities for NanosphereProtein biomarker capabilities for Nanosphere
Protein biomarker capabilities for Nanosphere
 
Role of Bioinformatics in COVID 19
Role of Bioinformatics in COVID 19Role of Bioinformatics in COVID 19
Role of Bioinformatics in COVID 19
 
Newer diagnostic methods for tuberculosis
Newer  diagnostic  methods for tuberculosis  Newer  diagnostic  methods for tuberculosis
Newer diagnostic methods for tuberculosis
 
2007 pcrrflp csp variants
2007 pcrrflp csp variants2007 pcrrflp csp variants
2007 pcrrflp csp variants
 
Transcriptomics: A Tool for Plant Disease Management
Transcriptomics: A Tool for Plant Disease ManagementTranscriptomics: A Tool for Plant Disease Management
Transcriptomics: A Tool for Plant Disease Management
 
Newer investigations of tuberculosis
Newer investigations of tuberculosisNewer investigations of tuberculosis
Newer investigations of tuberculosis
 
I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad I Jornada Actualización en Genética Reproductiva y Fertilidad
I Jornada Actualización en Genética Reproductiva y Fertilidad
 
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...
CHARACTERISING FOOT-AND-MOUTH DISEASE VIRUS IN CLINICAL SAMPLES USING NANOPOR...
 
Kelley VanBuskirk
Kelley VanBuskirkKelley VanBuskirk
Kelley VanBuskirk
 
Xpert MTB/RIF Ultra newer technology past to future DIAGNOSIS OF TUBERCULOSIS
Xpert MTB/RIF Ultranewer technologypast to future DIAGNOSIS OF TUBERCULOSIS Xpert MTB/RIF Ultranewer technologypast to future DIAGNOSIS OF TUBERCULOSIS
Xpert MTB/RIF Ultra newer technology past to future DIAGNOSIS OF TUBERCULOSIS
 
ESTABLISHING MYCOBACTERIOLOGY LABORATORY SERVICES
ESTABLISHING MYCOBACTERIOLOGY LABORATORY SERVICESESTABLISHING MYCOBACTERIOLOGY LABORATORY SERVICES
ESTABLISHING MYCOBACTERIOLOGY LABORATORY SERVICES
 
Capnocytophaga canimorsus
Capnocytophaga canimorsus Capnocytophaga canimorsus
Capnocytophaga canimorsus
 
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
Detection of Wuchereria bancrofti DNA in paired serum and urine samples using...
 
transforming clinical microbiology by next generation sequencing
transforming clinical microbiology by next generation sequencingtransforming clinical microbiology by next generation sequencing
transforming clinical microbiology by next generation sequencing
 

Similaire à Meno K.D. - Research Report Presentation

Poster Noro 2016 Faculty day.pptx (2)
Poster Noro 2016 Faculty day.pptx (2)Poster Noro 2016 Faculty day.pptx (2)
Poster Noro 2016 Faculty day.pptx (2)Kgothatso Meno
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPnavinthakkar
 
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...IOSRJPBS
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany Elshamy
 
Basic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshneyBasic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshneyVanshikaVarshney5
 
Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Pranav Sopory
 
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...Detection of hepatitis b virus dna among abdominal typhus patients with hepat...
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...Alexander Decker
 
Diagnosis of Female Genital TB
Diagnosis of Female Genital TBDiagnosis of Female Genital TB
Diagnosis of Female Genital TBAnuj Sharma
 
Hbv genotypes in libya
Hbv genotypes in libyaHbv genotypes in libya
Hbv genotypes in libyaMilud Salem
 
Applications of Single Cell Analysis
Applications of Single  Cell AnalysisApplications of Single  Cell Analysis
Applications of Single Cell AnalysisQIAGEN
 
Next Generation Sequencing
Next Generation SequencingNext Generation Sequencing
Next Generation SequencingAamir Wahab
 
Horse gut microbiome
Horse gut microbiomeHorse gut microbiome
Horse gut microbiomeShebl E Salem
 
Gene sequencing and tb – a new age approach.pptx
Gene sequencing and tb – a new age approach.pptxGene sequencing and tb – a new age approach.pptx
Gene sequencing and tb – a new age approach.pptxShajahanPS
 
Role of pcr in diagnostics
Role of pcr in diagnosticsRole of pcr in diagnostics
Role of pcr in diagnosticsTariq Mahmood
 
STDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxSTDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxKamalJungShahi
 
Pawlotsky jm résist tt hcv 2014
Pawlotsky jm  résist tt hcv 2014Pawlotsky jm  résist tt hcv 2014
Pawlotsky jm résist tt hcv 2014odeckmyn
 

Similaire à Meno K.D. - Research Report Presentation (20)

Poster Noro 2016 Faculty day.pptx (2)
Poster Noro 2016 Faculty day.pptx (2)Poster Noro 2016 Faculty day.pptx (2)
Poster Noro 2016 Faculty day.pptx (2)
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCP
 
Publication 3 - 3rd Author
Publication 3 - 3rd AuthorPublication 3 - 3rd Author
Publication 3 - 3rd Author
 
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide results
 
Basic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshneyBasic knowledge of_viral_metagenome_vanshika-varshney
Basic knowledge of_viral_metagenome_vanshika-varshney
 
Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)Current status of Malaria vaccine (Nov 2016)
Current status of Malaria vaccine (Nov 2016)
 
220620-FEMS-2022-FQ_final.pdf
220620-FEMS-2022-FQ_final.pdf220620-FEMS-2022-FQ_final.pdf
220620-FEMS-2022-FQ_final.pdf
 
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...Detection of hepatitis b virus dna among abdominal typhus patients with hepat...
Detection of hepatitis b virus dna among abdominal typhus patients with hepat...
 
220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf
 
Diagnosis of Female Genital TB
Diagnosis of Female Genital TBDiagnosis of Female Genital TB
Diagnosis of Female Genital TB
 
Hbv genotypes in libya
Hbv genotypes in libyaHbv genotypes in libya
Hbv genotypes in libya
 
Applications of Single Cell Analysis
Applications of Single  Cell AnalysisApplications of Single  Cell Analysis
Applications of Single Cell Analysis
 
Next Generation Sequencing
Next Generation SequencingNext Generation Sequencing
Next Generation Sequencing
 
Horse gut microbiome
Horse gut microbiomeHorse gut microbiome
Horse gut microbiome
 
Gene sequencing and tb – a new age approach.pptx
Gene sequencing and tb – a new age approach.pptxGene sequencing and tb – a new age approach.pptx
Gene sequencing and tb – a new age approach.pptx
 
Role of pcr in diagnostics
Role of pcr in diagnosticsRole of pcr in diagnostics
Role of pcr in diagnostics
 
STDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptxSTDS- recent diagnosis methods@1223.pptx
STDS- recent diagnosis methods@1223.pptx
 
Pawlotsky jm résist tt hcv 2014
Pawlotsky jm  résist tt hcv 2014Pawlotsky jm  résist tt hcv 2014
Pawlotsky jm résist tt hcv 2014
 
05_IJPBA_1907_21.pdf
05_IJPBA_1907_21.pdf05_IJPBA_1907_21.pdf
05_IJPBA_1907_21.pdf
 

Meno K.D. - Research Report Presentation

  • 1. Kgothatso (KD) Meno BSc (Hons) Department of Medical Virology Supervisor: Co-Supervisor: Dr J Mans Prof MB Taylor
  • 2.  Noroviruses are a major cause of gastroenteritis worldwide in humans and animals  It affects people of all ages  Children, elderly and immunocompromised patients are at risk of severe disease  Norovirus is a highly contagious virus, 18 viral particles can initiate an infection
  • 3.  Transmission by means of faecal-oral route  The symptoms shown by an individual who is infected by NoVs include nausea, vomiting, non- bloody watery diarrhoea and fever  Virus shedding for 3 weeks after infection  Prolonged in immunocompromised individuals  200 000 deaths of children younger than five years old has been estimated in the developing world annually
  • 4. Norovirus (NoV) - A member of Caliciviridae family Small (30 to 35 nm), non-enveloped, icosahedral Linear, positive sense, single-stranded RNA genome
  • 5. Norovirus Genome  ORF1/2 polymerase-capsid junction used for detection and genotyping NoVs  NoVs are divided into six genogroups, seventh has been proposed (Genogroups I, II and IV infect humans)  GII.4 is the most prevalent of all genotypes Structural Protein (VP1) / Major Capsid Protein Non-structural proteins including RNA-dependent RNA polymerase
  • 6.  Norovirus Capsid Model of VP1 dimer
  • 7.  To date no commercial NoV vaccine exists  Virus like particles (VLP) vaccines are in clinical trials (Atmar et al., NEJM, 2011)  Vaccine has been shown to prevent disease but not infection  Studies are ongoing to evaluate combinations of genogroups and other aspects of the vaccine
  • 8.  No specific treatment or antiviral therapy for NoV infection  Treatment: intravenous or oral hydration  At least 40 genotypes within the 6 genogroups
  • 10.  A large number of gastroenteric infections and outbreaks caused by NoVs are reported but many suspected cases are not laboratory confirmed  The degree of genetic variability in NoVs makes it difficult to design sensitive and specific molecular diagnostic assays  This increases the need and impact of primer design that is optimised for molecular detection and typing
  • 11.  Real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) is considered the “gold standard” for detection of NoVs  Laboratory confirmation of NoV is important in public health remediation and prevention as well as enhancing the understanding of NoV prevalence in the population
  • 12.  Genogroup distribution in South Africa (2009- 2015)  GI (17.7%)  GII (78.5%)  GI+GII (3.8%)  Sizable proportion caused by GI  GI detected but not possible to genotype, there is diversity primers are not picking up
  • 13.  Since GII is studied more globally, there is lack of information on GI because research is skewed to GII  The number of complete genome sequences of GI Vs. GII  GI is circulating a lot in SA but complete genomes are missing  In HIV positive children, more severe disease is associated with GI (Prof NA Page)  GI might be a more relevant genogroup in SA
  • 14.  To optimise NoV GI genotyping primers and to apply the newly developed genotyping assay to study NoV GI diversity in clinical specimens and the environment
  • 15.  To genotype NoV GI detected from sewage samples (April 2015- March 2016) using standard GI primers targeting the polymerase and capsid regions  To construct and analyse multiple alignments of available GI sequences from GenBank  To design primers to optimise conventional RT-PCR  To apply optimised methods to genotype NoV GI strains from the Rotavirus Surveillance Sentinel Programme that could not be typed previously (2011- 2013) and new strains from 2015  To amplify complete capsid gene from selected GI strains for characterisation and phylogenetic analysis
  • 16. Sample selecion Sewage samples (Apr 2015-March 2016) Stool specimens (<5 yrs with diarrhoea from RSSP) Recovery + extraction (Victor Mabasa) Manual nucleic acid extraction RNA Primer optimisation Genotyping cDNA Semi-nested RT-PCR (partial capsid and RdRp)
  • 17. Sewage Cloning Colony PCR Stool Specimens Direct sequencing Sequencing Phylogenetic Analysis
  • 18. Rand Water Project 2015/2016 NoV GI Positive Samples – April 2015* to March 2016 4 31 9 Samples Unscreened Screened Unscreened Ct>37 n=44
  • 19. 0 1 2 3 4 5 6 7 8 GIpositives Months Representation of number of norovirus GI positive samples detected by real-time RT-qPCR and typed by Semi-nested conventional PCR Real-time detection nested PCR typing
  • 20. Round 1 Round 2 1kb+ marker PCR & CDNA negative Round 1 Round 2 Round 2Round 1 M M M M M
  • 22. Distribution of genotypes: all samples sequenced were GI.4 25 6 4 Negative Positive Still to be screened n=35
  • 23.  Collected all the complete genomes (33)  Typed them using the norovirus genotyping tool and aligned them using MAFFT software in FASTA format  Distribution of genotypes GI.1 22 GI.2 3 GI.3 2 G1.4 1 GI.6 3 GI.8 2
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.  GI Forward primer 1 TGG ACA GGA GAT CGC RAT CT Tm:66°C  GI Forward primer 2 ATG ATG ATG GCG TCT AAG GA Tm:61°C  GI Reverse primer CCI ACC CAI CCA TTR TAC AT Tm:61°C
  • 29.  Problems encountered:  Encountered problems with the Hot Start DNA polymerase enzyme, a lot of sewage samples were screened but there was no amplification  Although the enzyme worked on clinical specimens  The standard primer binding region not completely conserved  The denaturation time (30 sec) too short
  • 30.  Alternative ways attempted:  A different enzyme (Emerald) was used, there was amplification  High number of none specific amplification  Emerald PCR products: Gel clean up
  • 31.  Use my designed primers on the stool specimens  Go back and screen some of the sewage samples with the new optimised primers and the Hot start DNA polymerase  Go back and screen the previously negative sewage samples with Emerald enzyme  Optimise the Emerald PCR  Design genotype specific primer for capsid 3’ end  Amplify and sequence the complete capsid gene of selected strains
  • 32.
  • 33. Part of a larger (ethically approved) project (Rotavirus Sentinel Surveillance Programme), additional ethical approval has been granted (127/2016) Total: R71 850
  • 34.  Prof NA Page together with the Rota network  Randwater  NRF